EDGAR Filing Documents for 0001193805-17-001210

Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

SEC Accession No. 0001193805-17-001210

Filing Date

2017-06-30

Accepted

2017-06-29 17:58:08

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13G	sc13g07422cyt_06292017.htm	SC 13G	207463
2	JOINT FILING AGREEMENT	ex991to13g07422cyt_062917.htm	EX-99.1	12715
	Complete submission text file	0001193805-17-001210.txt		221747

Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104

Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89140 | Film No.: 17939739
SIC: 2834 Pharmaceutical Preparations